{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T20:02:27Z","timestamp":1791662547153,"version":"4.3.4"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Research"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1016\/j.phrs.2022.106415","type":"journal-article","created":{"date-parts":[[2022,8,25]],"date-time":"2022-08-25T10:15:31Z","timestamp":1661422531000},"page":"106415","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":36,"special_numbering":"C","title":["Voacamine is a novel inhibitor of EGFR exerting oncogenic activity against colorectal cancer through the mitochondrial pathway"],"prefix":"10.1016","volume":"184","author":[{"given":"Yao","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jirui","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Zuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaozheng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiru","family":"Pu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunqian","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ouyang","family":"You","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xila","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aiping","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjun","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.phrs.2022.106415_bib1","first-page":"145","article-title":"Colorectal cancer statistics, 2020","volume":"70","author":"Siegel","year":"2020","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.phrs.2022.106415_bib2","doi-asserted-by":"crossref","first-page":"5076","DOI":"10.1038\/s41388-019-0780-z","article-title":"Dissecting mechanisms of resistance to targeted drug combination therapy in human colorectal cancer","volume":"38","author":"Clarke","year":"2019","journal-title":"Oncogene"},{"key":"10.1016\/j.phrs.2022.106415_bib3","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1002\/cam4.2108","article-title":"Traditional Chinese medicine as a cancer treatment: modern perspectives of ancient but advanced science","volume":"8","author":"Xiang","year":"2019","journal-title":"Cancer Med."},{"key":"10.1016\/j.phrs.2022.106415_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2020.105377","article-title":"Triptolide delivery: nanotechnology-based carrier systems to enhance efficacy and limit toxicity","volume":"165","author":"Ren","year":"2021","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.phrs.2022.106415_bib5","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1007\/s13346-019-00682-7","article-title":"Paclitaxel loaded EDC-crosslinked fibroin nanoparticles: a potential approach for colon cancer treatment","volume":"10","author":"Pham","year":"2020","journal-title":"Drug Deliv. Transl. Res."},{"key":"10.1016\/j.phrs.2022.106415_bib6","series-title":"Structural Diversity and Biological Activities of Caged Garcinia Xanthones: Recent Updates","author":"Phang","year":"2022"},{"key":"10.1016\/j.phrs.2022.106415_bib7","doi-asserted-by":"crossref","first-page":"751","DOI":"10.2174\/1389557517666170927154231","article-title":"Marine natural product bis-indole alkaloid caulerpin: chemistry and biology","volume":"19","author":"Lunagariya","year":"2019","journal-title":"Mini Rev. Med. Chem."},{"key":"10.1016\/j.phrs.2022.106415_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.tiv.2020.104819","article-title":"Voacamine: alkaloid with its essential dimeric units to reverse tumor multidrug resistance","volume":"65","author":"Condello","year":"2020","journal-title":"Toxicol. Vitr."},{"key":"10.1016\/j.phrs.2022.106415_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2022.154015","article-title":"Activation of mitochondrial-associated apoptosis signaling pathway and inhibition of PI3K\/Akt\/mTOR signaling pathway by voacamine suppress breast cancer progression","author":"Zuo","year":"2022","journal-title":"Phytomedicine"},{"key":"10.1016\/j.phrs.2022.106415_bib10","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.bcp.2017.05.002","article-title":"Voacamine alters Leishmania ultrastructure and kills parasite by poisoning unusual bi-subunit topoisomerase IB","volume":"138","author":"Chowdhury","year":"2017","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.phrs.2022.106415_bib11","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.2174\/1389450120666190618123846","article-title":"PI3K\/Akt\/mTOR pathway as a therapeutic target for colorectal cancer: a review of preclinical and clinical evidence","volume":"20","author":"Narayanankutty","year":"2019","journal-title":"Curr. Drug Targets"},{"key":"10.1016\/j.phrs.2022.106415_bib12","doi-asserted-by":"crossref","first-page":"2460","DOI":"10.1002\/jcb.25950","article-title":"Therapeutic potential of targeting PI3K\/AKT pathway in treatment of colorectal cancer: rational and progress","volume":"119","author":"Bahrami","year":"2018","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.phrs.2022.106415_bib13","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.gene.2005.10.018","article-title":"Epidermal growth factor receptor (EGFR) signaling in cancer","volume":"366","author":"Normanno","year":"2006","journal-title":"Gene"},{"key":"10.1016\/j.phrs.2022.106415_bib14","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1111\/j.1742-4658.2009.07448.x","article-title":"Epidermal growth factor receptor in relation to tumor development: EGFR gene and cancer, The","volume":"277","author":"Mitsudomi","year":"2010","journal-title":"FEBS J."},{"key":"10.1016\/j.phrs.2022.106415_bib15","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1021\/ci100436p","article-title":"FRED pose prediction and virtual screening accuracy","volume":"51","author":"McGann","year":"2011","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.phrs.2022.106415_bib16","doi-asserted-by":"crossref","first-page":"315","DOI":"10.3389\/fchem.2018.00315","article-title":"Advances in the development of shape similarity methods and their application in drug discovery","volume":"6","author":"Kumar","year":"2018","journal-title":"Front. Chem."},{"key":"10.1016\/j.phrs.2022.106415_bib17","doi-asserted-by":"crossref","first-page":"134","DOI":"10.3390\/cancers12010134","article-title":"Mu opioid receptor 1 (MOR-1) expression in colorectal cancer and oncological long-term outcomes: a five-year retrospective longitudinal cohort study","volume":"12","author":"D\u00edaz-Cambronero","year":"2020","journal-title":"Cancers"},{"key":"10.1016\/j.phrs.2022.106415_bib18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s12276-018-0128-8","article-title":"Wnt pathway is involved in 5-FU drug resistance of colorectal cancer cells","volume":"50","author":"He","year":"2018","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.phrs.2022.106415_bib19","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.drudis.2015.09.003","article-title":"Modelling of compound combination effects and applications to efficacy and toxicity: state-of-the-art, challenges and perspectives","volume":"21","author":"Bulusu","year":"2016","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.phrs.2022.106415_bib20","series-title":"Vinblastine and Vincristine, Natural Small Molecule Drugs from Plants","first-page":"551","author":"Zhang","year":"2018"},{"key":"10.1016\/j.phrs.2022.106415_bib21","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1016\/S0031-9422(00)83488-3","article-title":"Antimicrobially active alkaloids from Tabernaemontana pachysiphon","volume":"23","author":"Van Beek","year":"1984","journal-title":"Phytochemistry"},{"key":"10.1016\/j.phrs.2022.106415_bib22","first-page":"30","article-title":"Biological activities of the plant-derived bisindole voacamine with reference to malaria","volume":"15","author":"Ramanitrahasimbola","year":"2001","journal-title":"Phytother. Res. Int. J. Devoted Pharmacol. Toxicol. Eval. Nat. Prod. Deriv."},{"key":"10.1016\/j.phrs.2022.106415_bib23","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1021\/np400950h","article-title":"Voacamine modulates the sensitivity to doxorubicin of resistant osteosarcoma and melanoma cells and does not induce toxicity in normal fibroblasts","volume":"77","author":"Condello","year":"2014","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.phrs.2022.106415_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2022.154015","article-title":"Activation of mitochondrial-associated apoptosis signaling pathway and inhibition of PI3K\/Akt\/mTOR signaling pathway by voacamine suppress breast cancer progression","volume":"99","author":"Zuo","year":"2022","journal-title":"Phytomedicine"},{"key":"10.1016\/j.phrs.2022.106415_bib25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41419-018-0550-9","article-title":"KIF4A facilitates cell proliferation via induction of p21-mediated cell cycle progression and promotes metastasis in colorectal cancer","volume":"9","author":"Hou","year":"2018","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.phrs.2022.106415_bib26","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1007\/BF01269891","article-title":"Overexpression of cyclin B1 in human colorectal cancers","volume":"123","author":"Wang","year":"1997","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"10.1016\/j.phrs.2022.106415_bib27","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1038\/bjc.2012.463","article-title":"Expression of cyclin D1a and D1b as predictive factors for treatment response in colorectal cancer","volume":"107","author":"Myklebust","year":"2012","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.phrs.2022.106415_bib28","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2020.558414","article-title":"The anti-tumor effects of p-coumaric acid on melanoma A375 and B16 cells","volume":"10","author":"Hu","year":"2020","journal-title":"Front. Oncol."},{"key":"10.1016\/j.phrs.2022.106415_bib29","first-page":"256","article-title":"Tumor characteristics, expressions of ERCC1, Bax, p53, IGF1R, Bcl2, Bcl2\/Bax and prognostic factors for overall survival in patients with lung carcinoid","volume":"24","author":"Velinovic","year":"2019","journal-title":"J. BUON"},{"key":"10.1016\/j.phrs.2022.106415_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2019.109712","article-title":"Zinc oxide nanoparticles induce human multiple myeloma cell death via reactive oxygen species and Cyt-C\/Apaf-1\/Caspase-9\/Caspase-3 signaling pathway in vitro","volume":"122","author":"Li","year":"2020","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.phrs.2022.106415_bib31","doi-asserted-by":"crossref","first-page":"5971","DOI":"10.1038\/onc.2015.45","article-title":"An EGFR\/PI3K\/AKT axis promotes accumulation of the Rac1-GEF Tiam1 that is critical in EGFR-driven tumorigenesis","volume":"34","author":"Zhu","year":"2015","journal-title":"Oncogene"}],"container-title":["Pharmacological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661822003607?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661822003607?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T22:34:48Z","timestamp":1760913288000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043661822003607"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":31,"alternative-id":["S1043661822003607"],"URL":"https:\/\/doi.org\/10.1016\/j.phrs.2022.106415","relation":{},"ISSN":["1043-6618"],"issn-type":[{"value":"1043-6618","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Voacamine is a novel inhibitor of EGFR exerting oncogenic activity against colorectal cancer through the mitochondrial pathway","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phrs.2022.106415","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"106415"}}